NEWS and OPINIONS

Tailoring cell therapies for diabetic metabolic phenotypes: a comparative study on the efficacy of various umbilical cord-derived cell regimens
By Stem Cells Translational Medicine Given the high heterogeneity of type 2 diabetes mellitus (T2DM), it is imperative to develop personalized stem cell infusion regimen for targeted metabolic phenotype in order to ensure optimal therapeutic efficacy. In this study,...

Researchers Make Breakthrough in Bioprinting Functional Human Heart Tissue
By Technology Networks - Researchers at University of Galway have developed a way of bioprinting tissues that change shape as a result of cell-generated forces, in the same way that it happens in biological tissues during organ development. The breakthrough science...

UCLA scientists awarded $21.8 million in CIRM grants to advance novel stem-cell based therapies
by Linda Wang - UCLA Health - Scientists at the Eli and Edythe Broad Center of Regenerative Medicine and Stem Cell Research at UCLA have received $21.8 million in grants from the California Institute for Regenerative Medicine, the state’s stem cell agency, to develop...

‘Fatty cartilage’ discovery set to revolutionize regenerative medicine
By Paul McClure - New Atlas - Researchers have discovered a new type of tissue, a soft and flexible ‘fatty cartilage’ that could revolutionize the treatment of traumatic injuries, birth defects, and cartilage-damaging diseases like osteoarthritis, rheumatoid arthritis...

New study shows stem cell therapy ‘jump-start’ brain repair after stroke
by Gladstone Institutes - MedicalXpress - Every 40 seconds, someone in the United States has a stroke. For survivors of the most common type of stroke, called an ischemic stroke, only about 5 percent fully recover. Most others suffer from long-term problems, including...

Korea permits stem cell therapies for arthritis, autoimmune diseases, and Parkinson’s patients
By Heo Ji-yoon - Chosun Biz - Korean patients gain access to innovative regenerative medical treatments after law changes. Next month, patients with severe, rare, and incurable diseases such as arthritis, autoimmune diseases, Parkinson's disease, and cancer will be...

It was so easy to give people more years of life with my Stem Cells
by Storm Newton - BBC - A man has given his stem cells twice in the space of a decade to help save the lives of two people. Brad Green, from Sheffield, was inspired to sign the Anthony Nolan stem cell register at the age of 20 after a school friend's dad was diagnosed...

Healthspan Compass – Vol. 9 – from Healthspan Action Coalition
By Eve Herold - Healthspan Action Coalition - Before we launch into news on the healthspan front, let’s acknowledge the elephant in the room. US health agencies, including the National Institutes of Health and the FDA, are currently in a state of limbo as the dust...

Princeton bioengineers shed light on how and when embryonic cells organize themselves
By Wright Seneres - Princeton Engineering - For decades, scientists have puzzled over how a symmetrical ball of cells becomes an embryo, with the beginnings of a head and tail. Now Princeton engineers have discovered that this transformation from perfect symmetry to...

Youthful Brain Stem Cells Linked to Autism and Brain Cancer
By Neuroscience News - Researchers have identified a unique stem cell in the young brain capable of maturing into multiple cell types, potentially explaining the origins of autism and glioblastoma. These stem cells show gene expression patterns that regulate early...
The compassionate team behind CAR T cancer breakthroughs
By: Nicole Sweeney Etter - Penn Medicine News - For more than a decade, Penn Medicine clinical research nurse Joanne Shea, MS, BSN, RN, has had a front-row seat to the groundbreaking research underway in the Center for Cellular Immunotherapies. As Abramson Cancer...

JPM25: Bayer moves allogeneic cell therapy into phase 3 Parkinson’s trial
By Gabrielle Masson - Fierce Biotech - Bayer’s Parkinson’s disease cell therapy is moving into late-stage testing, with the upcoming trial set to be the first registrational phase 3 study for an investigational allogeneic cell therapy in the neurodegenerative disease....